Dynavax Technologies
DVAX
$9.86
Share price
0.82%
Change (1 day)
-9.79%
Change (1 year)
Categories
Market capitalization of Dynavax Technologies (DVAX)
Market cap: $1.25 Billion
As of March 2023 Dynavax Technologies has a market cap of $1.25 Billion. This makes Dynavax Technologies the world's 4312th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Dynavax Technologies from 2004 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $1.25 B | -7.26% |
| 2022 | $1.35 B | -19.57% |
| 2021 | $1.68 B | 244.19% |
| 2020 | $0.49 B | 2.21% |
| 2019 | $0.47 B | -16.59% |
| 2018 | $0.57 B | -49.24% |
| 2017 | $1.13 B | 644.59% |
| 2016 | $0.15 B | -83.62% |
| 2015 | $0.92 B | 109.42% |
| 2014 | $0.44 B | -13.89% |
| 2013 | $0.51 B | -1.13% |
| 2012 | $0.52 B | 23.74% |
| 2011 | $0.42 B | 13.8% |
| 2010 | $0.36 B | 379.99% |
| 2009 | $77.07 M | 130.23% |
| 2008 | $33.47 M | -83.52% |
| 2007 | $0.20 B | -44.27% |
| 2006 | $0.36 B | 265.8% |
| 2005 | $99.66 M | -47.38% |
| 2004 | $0.18 B |
End of Day market cap according to different sources
On Mar 25th, 2023 the market cap of Dynavax Technologies was reported to be:
$1.25 Billion
$1.25 Billion
$1.25 Billion
$1.25 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $227.97 B | 18,007.90% | 🇺🇸 USA |
 Amgen AMGN | $127.10 B | 9,995.55% | 🇺🇸 USA |
 Biogen BIIB | $39.01 B | 2,998.95% | 🇺🇸 USA |
 Gilead Sciences GILD | $99.76 B | 7,824.49% | 🇺🇸 USA |
 Merck MRK | $266.04 B | 21,031.50% | 🇺🇸 USA |
 AstraZeneca AZN | $210.49 B | 16,619.59% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $70.39 B | 5,491.13% | 🇬🇧 UK |
 Agenus
AGEN | $0.49 B | -60.65% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $9.51 B | 655.88% | 🇮🇱 Israel |